| Adenosine and selective A2A receptor agonists reduce ischemia/reperfusion injury of rat liver mainly by inhibiting leukocyte activation N Harada, K Okajima, K Murakami, S Usune, C Sato, K Ohshima, ... Journal of Pharmacology and Experimental Therapeutics 294 (3), 1034-1042, 2000 | 164* | 2000 |
| Acute kidney injury in the ICU: from injury to recovery: reports from the 5th Paris International Conference R Bellomo, C Ronco, RL Mehta, P Asfar, J Boisramé-Helms, M Darmon, ... Annals of intensive care 7 (1), 49, 2017 | 83 | 2017 |
| Alkaline phosphatase: a possible treatment for sepsis-associated acute kidney injury in critically ill patients E Peters, S Heemskerk, R Masereeuw, P Pickkers American journal of kidney diseases 63 (6), 1038-1048, 2014 | 71 | 2014 |
| α7 nicotinic acetylcholine receptor agonist GTS-21 attenuates ventilator-induced tumour necrosis factor-α production and lung injury M Kox, JC Pompe, E Peters, M Vaneker, JW Van Der Laak, ... British journal of anaesthesia 107 (4), 559-566, 2011 | 57 | 2011 |
| A worldwide multicentre evaluation of the influence of deterioration or improvement of acute kidney injury on clinical outcome in critically ill patients with and without … E Peters, M Antonelli, X Wittebole, R Nanchal, B François, Y Sakr, ... Critical Care 22 (1), 188, 2018 | 52 | 2018 |
| Alkaline phosphatase protects against renal inflammation through dephosphorylation of lipopolysaccharide and adenosine triphosphate E Peters, S Geraci, S Heemskerk, MJ Wilmer, A Bilos, B Kraenzlin, ... British journal of pharmacology 172 (20), 4932-4945, 2015 | 47 | 2015 |
| Alkaline phosphatase as a treatment of sepsis-associated acute kidney injury E Peters, A van Elsas, S Heemskerk, L Jonk, J van der Hoeven, J Arend, ... Journal of pharmacology and experimental therapeutics 344 (1), 2-7, 2013 | 42 | 2013 |
| Study protocol for a multicentre randomised controlled trial: Safety, Tolerability, efficacy and quality of life Of a human recombinant alkaline Phosphatase in patients with … E Peters, RL Mehta, PT Murray, J Hummel, M Joannidis, JA Kellum, ... BMJ open 6 (9), e012371, 2016 | 28 | 2016 |
| The potential of alkaline phosphatase as a treatment for sepsis-associated acute kidney injury E Peters, R Masereeuw, P Pickkers Nephron Clinical Practice 127 (1-4), 144-148, 2014 | 27 | 2014 |
| The involvement of danger-associated molecular patterns in the development of immunoparalysis in cardiac arrest patients K Timmermans, M Kox, J Gerretsen, E Peters, GJ Scheffer, ... Critical care medicine 43 (11), 2332-2338, 2015 | 24 | 2015 |
| Short-term hypoxia dampens inflammation in vivo via enhanced adenosine release and adenosine 2B receptor stimulation D Kiers, B Wielockx, E Peters, LT van Eijk, J Gerretsen, A John, E Janssen, ... EBioMedicine 33, 144-156, 2018 | 23 | 2018 |
| Effects of a human recombinant alkaline phosphatase on renal hemodynamics, oxygenation and inflammation in two models of acute kidney injury E Peters, B Ergin, A Kandil, E Gurel-Gurevin, A van Elsas, R Masereeuw, ... Toxicology and applied pharmacology 313, 88-96, 2016 | 23 | 2016 |
| Effects of the humanized anti-adrenomedullin antibody adrecizumab (HAM8101) on vascular barrier function and survival in rodent models of systemic inflammation and sepsis C Geven, E Peters, M Schroedter, J Struck, A Bergmann, O McCook, ... Shock 50 (6), 648-654, 2018 | 19 | 2018 |
| Pharmacokinetic modeling and dose selection in a randomized, double-blind, placebo-controlled trial of a human recombinant alkaline phosphatase in healthy volunteers E Peters, JAAC Heuberger, R Tiessen, A van Elsas, R Masereeuw, ... Clinical pharmacokinetics 55 (10), 1227-1237, 2016 | 14 | 2016 |
| Tubular injury biomarkers to detect gentamicin-induced acute kidney injury in the neonatal intensive care unit D Jansen, E Peters, S Heemskerk, L Koster-Kamphuis, MP Bouw, ... American journal of perinatology 33 (02), 180-187, 2016 | 13 | 2016 |
| Biodistribution and translational pharmacokinetic modeling of a human recombinant alkaline phosphatase E Peters, J Stevens, J Arend, Z Guan, W Raaben, P Laverman, ... International journal of pharmaceutics 495 (1), 122-131, 2015 | 12 | 2015 |
| Effects of a human recombinant alkaline phosphatase during impaired mitochondrial function in human renal proximal tubule epithelial cells E Peters, T Schirris, AH van Asbeck, J Gerretsen, J Eymael, A Ashikov, ... European journal of pharmacology 796, 149-157, 2017 | 9 | 2017 |
| 36th International Symposium on Intensive Care and Emergency Medicine RM Bateman, MD Sharpe, JE Jagger, CG Ellis, J Solé-Violán, ... Critical Care 20 (2), 13-182, 2016 | 8 | 2016 |
| Human recombinant alkaline phosphatase inhibits ex vivo platelet activation in humans RN Tunjungputri, E Peters, A van der Ven, PG de Groot, Q de Mast, ... Thrombosis and haemostasis 116 (12), 1111-1121, 2016 | 4 | 2016 |
| Pharmacokinetics, safety and tolerability of human recombinant alkaline phosphatase in healthy volunteers E Peters, J Arend, R Tiessen, A Van Elsas, R Masereeuw, P Pickkers Critical Care 19 (1), 1-201, 2015 | 2 | 2015 |
